久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

J&J fined $572m for role in US opioid crisis

By HENG WEILI in New York | China Daily Global | Updated: 2019-08-27 23:44
Share
Share - WeChat
A logo sign outside of a facility occupied by Johnson & Johnson in Irvine, California on Dec 9, 2017. [Photo/IC]

The opioid epidemic in the United States has claimed many victims, and a major pharmaceutical company was told Monday that it will be paying a hefty price for its involvement.

An Oklahoma judge determined that Johnson & Johnson was liable for fueling an opioid epidemic in the south central US state by deceptively marketing addictive painkillers and ordered the New Jersey-based drugmaker to pay $572.1 million.

Opioids were involved in almost 400,000 overdose deaths from 1999 to 2017, according to the US Centers for Disease Control and Prevention.

Since 2000, some 6,000 Oklahomans have died from opioid overdoses, according to the state's lawyers.

The trial came about after Oklahoma had resolved claims against OxyContin maker Purdue Pharma LP in March for $270 million and against Teva in May for $85 million, leaving J&J as the lone defendant.

Lawyers for Oklahoma argued that J&J— the first opioid maker to face trial — carried out a years-long marketing campaign that minimized the painkillers' addiction risks and promoted their benefits.

The state's witnesses cited statistics showing that enough opioids were dispensed in 2017 for every adult in Oklahoma to be given the equivalent of 156 hydrocodone 10 milligram tablets, according to The Oklahoman website.

Still, the award was well below what some investors and analysts feared, in what had been a $17 billion lawsuit viewed as a bellwether for other litigation nationwide over the opioid crisis.

"The expectation was this was going to be a $1.5 billion to $2 billion fine," said Jared Holz, healthcare strategist for Jefferies, adding that the $572 million "is a much lower number than had been feared".

As a result, J&J shares rose in after-hours trading.

J&J, the No. 37 company in the Fortune 500, said it would appeal to the Oklahoma Supreme Court and will look to put the award payment on hold.

"Janssen (a subsidiary of J&J) did not cause the opioid crisis in Oklahoma, and neither the facts nor the law support this outcome," Michael Ullmann, J&J's general counsel, said in a statement.

The decision by Judge Thad Balkman of Cleveland County District Court in Norman, Oklahoma, followed a seven-week non-jury trial.

The case brought by Oklahoma Attorney General Mike Hunter was the first to go to trial out of thousands of lawsuits filed by state and local governments against opioid manufacturers and distributors.

Oklahoma argued that J&J's marketing practices helped fuel the opioid epidemic by flooding the market with painkillers.

"Johnson & Johnson will finally be held accountable for thousands of deaths and addictions caused by their actions," Hunter said.

The attorney general has said that between 2015 and 2018, 18 million opioid prescriptions were written in Oklahoma, a state with around 4 million people.

Hunter said J&J "embarked on a cynical, deceitful, multibillion-dollar brainwashing campaign to establish opioid analgesics as the magic drug."

J&J has denied wrongdoing, saying its marketing claims had scientific support and that its painkillers, Duragesic and Nucynta, accounted for a small fraction of opioids prescribed in Oklahoma.

Ullmann faulted Oklahoma for attempting a "misapplication of public nuisance law" that judges in other states had already rejected.

Oklahoma sued J&J to help it address the epidemic for the next 30 years through treatment and prevention programs.

But the judge said the figure he awarded covered only one year, saying Oklahoma did not offer enough evidence of the time and costs to address the opioid crisis beyond that.

The litigation has been closely watched by plaintiffs in about 2,000 opioid lawsuits pending before a federal judge in Ohio.

Reuters contributed to this story.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 成人看片在线观看免费 | a级毛片毛片免费观看久潮喷 | 国产成人免费观看 | 男同黄网站 | 成人精品视频在线 | 99亚洲自拍 | 国产日韩欧美在线观看播放 | 99久久免费国产香蕉麻豆 | 中文字幕天堂久久精品 | 亚洲欧美日韩在线播放 | 又黄又www | 国产片在线天堂av | 久久中文字幕乱码免费 | 在线观看免费视频国产 | 天堂一区二区在线观看 | 99精品在免费线视频 | 在线观看aaa | 黄网在线观看免费网站台湾swag | 一级做a爰片久久毛片 | 久久久久国产精品美女毛片 | 欧美日韩一区二区在线 | 91日本在线精品高清观看 | 免费看欧美一级a毛片 | 成人国产在线视频在线观看 | 夜夜躁狠狠躁日日躁2021 | 国产免费视屏 | 欧美三级一级 | 两性色午夜视频免费国产 | 日韩精品一区二区三区中文在线 | 国产精品一区二区三区免费 | 亚洲精品天堂在线观看 | 久久精品高清 | 巨大热杵在腿间进进出出视频 | 久久久亚洲国产精品主播 | 国产高清一区二区三区免费视频 | 国产成人无精品久久久久国语 | 手机在线看a | 特黄特黄aaaa级毛片免费看 | 亚洲一级毛片中文字幕 | 欧洲色老头| 成人在线免费小视频 |